Norway’s public health institute on Thursday said the country should stop using the AstraZeneca vaccine, this announcement comes a day after Denmark’s decision to abandon the AstraZeneca COVID vaccine over links with very rare blood clots.
Euronews reported, both the World Health Organization and the European Medicines Agency have said the benefits of the vaccine outweigh its risks.
Geir Bukholm, director of infection control at Norway’s National Institute of Public Health said, “There is now significantly more knowledge about the connection between the AstraZeneca vaccine and the rare and serious incidents of low platelets, blood clots and bleeding than when Norway chose to put further use of the AstraZeneca vaccine on pause in March.”
“Based on this knowledge, we have arrived at a recommendation that the AstraZeneca vaccine be removed from the coronary vaccination programme in Norway.”
The authorities on March 11 had suspended the rollout of the vaccine after a small number of people who had received the dose were hospitalized with a combination of blood clots and a low count of platelets, with three cases proving fatal, according to reports of Euronews.
A Mental Health Chatbot Which Helps People With Depression Herbeauty Bukholm said that now, with “significantly more knowledge” about the connection between the AstraZeneca vaccine and rare incidents of blood clotting and low platelets, Norway should cease use of the vaccine.
It was estimated that the pulling of the AstraZeneca vaccine would likely bring about a delay in overall vaccine rollout by two weeks. Hence, Geir Bukholm said that it had not been easy to come to that recommendation.
However, he suggested he believe it was a necessary step. Moreover, Euronews said, those who have already received the first dose of the AstraZeneca vaccine are expected to be offered another coronavirus jab as their second dose.
However, the country’s public health institute said it would be offering more information on the specifics of the program in the coming days.